Two questions, not one
When a drug meets its target — say a receptor on a cell surface — two separate things matter, and they are easy to confuse. The first is how well the drug sticks: does it find the target, hold on, and resist falling off? That is affinity. The second is what the drug does after it sticks: does it switch the target on, switch it off, or merely occupy the space? That is the drug's intrinsic effect.
Here is why the distinction matters. Two molecules can bind a receptor with identical strength, yet one triggers a full biological response and the other triggers nothing at all while blocking the first. Binding tells you *where* and *how tightly*; it does not tell you *what happens next*. Pharmacodynamics is mostly the study of what happens next.
Agonists, antagonists, and intrinsic activity
Once a molecule binds, we classify it by what it does. An agonist binds and activates the target, producing the response the natural signal would. An antagonist binds but produces no response of its own — it simply occupies the site and prevents agonists from acting. The property that separates them is intrinsic activity: a number from 0 (pure antagonist) to 1 (full activator) describing how much response the bound drug can produce.
This is the heart of mechanism of action. When a pharmacologist asks "what does this compound do?" they are asking two things at once: how strongly does it engage the target, and which way does it push? The measured biological output — the bioactivity — is a product of both.
Same target, three molecules: Molecule A affinity HIGH intrinsic activity 1.0 -> full agonist (strong ON) Molecule B affinity HIGH intrinsic activity 0.0 -> antagonist (binds, does nothing, blocks A) Molecule C affinity LOW intrinsic activity 1.0 -> agonist but needs a big dose to act Notice: A and B bind equally well. The difference is NOT binding. Notice: A and C act the same way. The difference IS binding.
Why a chemist cares
For someone designing molecules, this split is liberating. You can often tune affinity and intrinsic activity separately with chemistry. Adding a group that fills a hydrophobic pocket may raise affinity without changing what the molecule does once bound. Changing a group that contacts a moving part of the receptor may flip a full agonist into an antagonist while affinity barely moves.